Upregulation of MiR-155 in Nasopharyngeal Carcinoma is Partly Driven by LMP1 and LMP2A and Downregulates a Negative Prognostic Marker JMJD1A

• Zi-Ming Du,

  Affiliations State Key Laboratory of Oncology in South China, and Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Li-Fu Hu,

  Affiliation Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Hai-Yun Wang,

  Affiliation State Key Laboratory of Oncology in South China, and Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China

  ⨯
• Li-Xu Yan,

  Affiliation State Key Laboratory of Oncology in South China, and Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China

  ⨯
• Yi-Xin Zeng,

  Affiliation State Key Laboratory of Oncology in South China, and Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China

  ⨯
• Jian-Yong Shao ,

  * E-mail: ingemar.ernberg@ki.se (IE); shaojy@sysucc.org.cn (JS)

  Affiliations State Key Laboratory of Oncology in South China, and Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Ingemar Ernberg

  * E-mail: ingemar.ernberg@ki.se (IE); shaojy@sysucc.org.cn (JS)

  Affiliation Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

  ⨯